As amyloid pathology is comparable between F+/T− mice and tau-seeded F+/T+ mice (Fig. 3), this suggests that under ATN pathology, some DAMs are not associated with amyloid plaques and likely arise in response to tau pathology and/or neurodegeneration [30]. The gene discussed is MAPT; the disease is oculocutaneous albinism type 1.